首页|辅酶Q10片辅助美托洛尔治疗高血压合并室性心律失常的效果

辅酶Q10片辅助美托洛尔治疗高血压合并室性心律失常的效果

扫码查看
目的 探究辅酶Q10片辅助美托洛尔在高血压合并室性心律失常患者中的应用效果。方法 采用回顾性研究,收集2021年1月至2023年12月医院接受美托洛尔治疗的52例高血压合并室性心律失常患者病历资料,纳入对照组;收集医院同期接受辅酶Q10片辅助美托洛尔治疗的52例高血压合并室性心律失常患者病历资料,纳入观察组,全部患者临床资料均保存完整。查阅患者病历资料,比较两组治疗效果,治疗前后血压指标、心率指标及心电图指标、心肌损伤指标,以及用药不良反应发生情况。结果 观察组总有效率为96。15%,高于对照组总有效率84。62%,差异有统计学意义(P<0。05);治疗后,两组舒张压与收缩压均降低,且观察组低于对照组,差异有统计学意义(P<0。05);治疗后,两组心率、窦性心律失常频次、QT间期离散度(QTd)、QT校正离散度(QTcd)均下降,且观察组低于对照组,差异有统计学意义(P<0。05);治疗后,两组心肌肌钙蛋白Ⅰ(cTnⅠ)、肌酸激酶同工酶(CK-MB)、肌红蛋白(Myo)均降低,且观察组低于对照组,差异有统计学意义(P<0。05);两组不良反应发生率比较,差异无统计学意义(P>0。05)。结论 辅酶Q10片辅助美托洛尔治疗高血压合并室性心律失常患者的临床效果显著,可以有效降低患者血压,改善心律失常症状,促进心肌细胞修复,且安全性好。
Effect of Coenzyme Q10 Tablets Assisting Metoprolol in the Treatment of Hypertension Combined with Ventricular Arrhythmias
Objective To explore the application effect of coenzyme Q10 tablets as an adjunct to metoprolol in patients with hypertension complicated with ventricular arrhythmias.Methods A retrospective study was conducted to collect medical records of 52 hypertensive patients with ventricular arrhythmias who received metoprolol treatment in the hospital from January 2021 to December 2023,and they were included in the control group.Medical records of 52 patients with hypertension complicated with ventricular arrhythmias who received coenzyme Q10 tablets as adjuvant therapy in the hospital were collected during the same period,and included in the observation group.All clinical data of patients were well preserved.The patient's medical records were reviewed,and the treatment effects,blood pressure indexes,heart rate indexes,electrocardiogram indexes,myocardial injury indexes before and after treatment,and the occurrence of adverse drug reactions were compared between the two groups.Results The total effective rate of the observation group was 96.15%,which was higher than the total effective rate of the control group by 84.62%,with a statistical significant difference(P<0.05).After treatment,both diastolic and systolic blood pressure decreased in both groups,and the observation group was lower than the control group,with a statistical significant difference(P<0.05).After treatment,the heart rate,frequency of sinus arrhythmias,QT interval dispersion(QTd),and QT corrected dispersion(QTcd)of both groups decreased,and the observation group was lower than the control group,with a statistical significant difference(P<0.05).After treatment,the levels of cardiac troponin Ⅰ(cTnⅠ),creatine kinase isoenzyme(CK-MB),and myoglobin(Myo)decreased in both groups,and the observation group was lower than the control group,with a statistical significant difference(P<0.05).There is no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The clinical effect of using coenzyme Q10 tablets as an adjunct to metoprolol in the treatment of hypertensive patients with ventricular arrhythmia is significant.It can effectively reduce blood pressure,improve arrhythmia symptoms,promote myocardial cell repair,and has good safety.

HypertensionVentricular ArrhythmiaMetoprololCoenzyme Q10 TabletsBlood PressureHeart RateAdverse Reactions

肖普、王蔚蔚

展开 >

郑州市第三人民医院心血管内科(河南郑州 450000)

高血压 室性心律失常 美托洛尔 辅酶Q10片 血压 心率 不良反应

2025

罕少疾病杂志
深圳市卫生局

罕少疾病杂志

影响因子:0.583
ISSN:1009-3257
年,卷(期):2025.32(1)